-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

704A.O3.6 704. Cellular Immunotherapies: Expanding Targets and Cellular Sources for Immunotherapies

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Clinical Trials, Biological, Non-Hodgkin Lymphoma, Clinical Research, Clinically Relevant, Diseases, SARS-CoV-2/COVID-19, Infectious Diseases, Therapies, Immunotherapy, Lymphoid Malignancies, Myeloid Malignancies, Natural Killer (NK) Cell Therapies
Monday, December 13, 2021: 4:30 PM-6:00 PM
Georgia Ballroom 1-3 (Georgia World Congress Center)
Moderators:
Rayne H. Rouce, MD , Clinical Care Center-Texas Children's Hospital and Manali Kamdar, MD, MDDS, University of Colorado
Disclosures:
Kamdar: TG Therapeutics, Genentech: Research Funding; AbbVie, AstraZeneca, Celgene/ Bristol-Myers Squibb, Adaptive Biotechnologies, ADC therapeutics, Beigene , Genentech: Consultancy; Sea Gen: Speakers Bureau.
4:30 PM

Veronika Bachanova, MD, PhD1, Armin Ghobadi, MD2, Krish Patel, MD3, Jae H Park, MD4, Ian W. Flinn, MD, PhD5, Prutha Shah, MBBS, MS6*, Carol Wong, MPH6*, Cara Bickers, PhD6*, Peter Szabo, MD, PhD6*, Lilly Wong, PhD6*, Bahram Valamehr, PhD7, Siminder Atwal, PhD6*, Yu-Waye Chu, MD6, Rebecca Elstrom, MD6 and Paolo Strati, MD8

1Masonic Cancer Center, University of Minnesota, Minneapolis, MN
2Washington University School of Medicine, St. Louis, MO
3Swedish Cancer Institute, Seattle, WA
4Memorial Sloan Kettering Cancer Center, New York, NY
5Sarah Cannon Research Institute, Nashville, TN
6Fate Therapeutics, Inc., San Diego, CA
7FateTherapeutics, Inc., San Diego, CA
8The University of Texas MD Anderson Cancer Center, Houston, TX

4:45 PM

Kunlin PEI, MD1*, Haoyu Xu, MD2*, Peng-Fei Wang3*, Wenting Gan3*, Zhengbin HU, MD4*, Yingyi He, M.D & Ph.D5* and Hui Zhang, MD, PhD6

1GuangZhou Women and Children's Medical Center, Guangzhou, China
2Guangzhou Women and Children's Medical Center, Guangzhou, China
3Guangzhou Women and Children's Medical Center, Guangzhou, CHN
4GUANGZHOU WOMEN AND CHILDREN'S MEDICAL CENTER, GUANGZHOU, China
5Department of Pediatric Hematology/Oncology, Guangzhou Women and Children’s Medical Center, Guangzhou, China
6Department of Hematology/oncology, St. Jude Children's Research Hospital, Shanghai, China

5:00 PM

David A. Sallman, MD1, Hany Elmariah, MD, MS2, Kendra Sweet, MD3, Chetasi Talati, MD1*, Asmita Mishra, MD4, Cheryl A Cox5*, Roshanak Semnani6*, Rutul R Shah7*, Helen Sabzevari, PhD7,8*, Marion Chakiath6*, Justin Uthuppan, BS2*, Amy Lankford, PhD9*, Chen Wang10*, Eric Padron, MD11, Andrew T. Kuykendall, MD12, Rami S. Komrokji, MD11, Jeffrey E. Lancet, MD13, Marco L. Davila, MD, PhD14 and Nelli Bejanyan, MD15

1Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL
2Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
3Department of Hematology and Oncology, Moffitt Cancer Center, Tampa, FL
4Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
5Cell Therapy Facility, Moffitt Cancer Center, Tampa, FL
6Precigen, Germantown, MD
7Precigen, Inc, Germantown, MD
8National Cancer Institute, National Institutes of Health, Bethesda, MD
9Precigen, Inc., Germantown, MD
10Department of Internal Medicine, University of South Florida, Tampa, FL
11Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
12Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
13Department of Malignant Hematology, H. Lee Moffitt Cancer Ctr. & Rsrch. Institute, Tampa, FL
14Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa
15Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL

5:15 PM

Chenggong Li1,2*, Qi Chang3*, Jing Wang4*, Mengyi Du1,2*, Lin Liu, MD, Ph.D1,5*, Haiming Kou1,5*, Cong Lu1,5*, Lu Tang1,5*, Jianghua Wu1,2*, Wenjing Luo1,5*, Yinqiang Zhang1,2*, Sha Ke1,5*, Jun Deng, MD, Ph.D1,5*, Cheng Liu, PhD3*, Yu Hu1,5* and Heng Mei1,5*

1Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, China
3Eureka Therapeutics, Inc, Emeryville
4Radiology Department, Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
5Hubei clinical medical center of cell therapy for neoplastic disease, Wuhan, China

5:30 PM

Sham Mailankody, MBBS 1, Claudia Diamonte, RN2*, Lisa Fitzgerald3*, Peter Kane, BA4*, Xiuyan Wang5*, Devanjan S. Sikder5*, Brigitte Senechal, PhD5*, Vladimir P. Bermudez5*, Diana Frias3*, Justina Morgan3*, Patrick Grant3*, Terence J Purdon, MS2*, Kinga Hosszu3*, Sean M Devlin, PhD6*, Urvi A Shah, MD1, Jonathan Landa, MD7*, Alexander Lesokhin, MD3, Neha Korde, MD1, Hani Hassoun, MD1, Carlyn Tan, MD3, Malin Hultcrantz, MD PhD1, Gunjan L. Shah, MD3, Heather J Landau, MD8, David J. Chung, MD, PhD9, Michael Scordo, MD10, Mikhail Roshal, MD, PhD11, Ola Landgren, MD12, Ahmet Dogan, MD, PhD13, Sergio A Giralt, MD14, Jae H Park, MD4, Isabelle Rivière, PhD5*, Renier J Brentjens, MD, PhD15 and Eric L. Smith, MD, PhD16

1Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
2Cellular Therapeutics Center, Memorial Sloan Kettering Cancer Center, New York, NY
3Memorial Sloan Kettering Cancer Center, New York, NY
4Cellular Therapeutics Service, Memorial Sloan Kettering Cancer Center, New York, NY
5Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center, New York, NY
6Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
7Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY
8Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY
9Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
10Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center/New York, New York, NY
11Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
12Myeloma Program, Department of Medicine, University of Miami, Sylvester Comprehensive Cancer Center, Miami
13Department of Pathology, Hematopathology Service, Memorial Sloan Kettering Cancer Center, New York, NY
14Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
15Memorial Sloan Kettering Cancer Center, Short Hills, NJ
16Medical Oncology, Dana-Farber Cancer Institute, Boston

5:45 PM

Douglas E Gladstone, MD1, Christopher Howard2*, Mi-Ae Lyu, Ph.D.3*, Jason Mock4*, Darryl Adams5*, Kevin Gibbs6*, Li Li, M.D.3*, Meixian Huang, M.D., Ph.D.3*, Ke Zeng, M.D.3, Franco D'Alessio7*, James Herlihy2*, Sergio Trevino2*, Parameswaran Hari8, Tara Sadeghi9*, Simrit Parmar, MBBS10, Arthur Slutsky11* and Siddhartha Mukherjee, MD, PhD12*

1Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD
2Baylor College of Medicine, Houston
3Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
4University of North Carolina, Chapel Hill
5Columbia University, New York
6Wakeforest University, Winston-Salem
7Johns Hopkins Hospital, Baltimore
8Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
9Cellenkos Inc., Houston, TX
10Department of Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, TX
11University of Toronto, Toronto, Canada
12Myelodysplastic Syndrome Center, Columbia University Medical Center, New York, NY

*signifies non-member of ASH